Global Recombinant Human Insulin Industry 2015 Market Research Report

Published: Jan, 2015 | Pages: 120 | Publisher: QYResearch
Industry: Biotechnology | Report Format: Electronic (PDF)

For overview analysis, the report introduces Recombinant Human Insulin basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.

For international and China market analysis, the report analyzes Recombinant Human Insulin markets in China and other countries or regions (such as US, Russia, etc.) by presenting research on global products of different types and applications, developments and trends of market, technology, and competitive landscape, and leading suppliers and countries’ 2009-2014 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and company contact information, etc. 2015-2020 forecast on capacity, production, cost, price, profit, production value, and gross margin for these markets are also included.

For technical data and manufacturing plants analysis, the report analyzes Recombinant Human Insulin leading suppliers on capacity, commercial production date, manufacturing plants distribution, R&D Status, technology sources, and raw materials sources.

This report also presents product specification, manufacturing process, and product cost structure etc. Production is separated by regions, technology and applications. Analysis also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals.

In the end, the report includes Recombinant Human Insulin new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis. In conclusion, it is a deep research report on Global Recombinant Human Insulin industry. Here, we express our thanks for the support and assistance from Recombinant Human Insulin industry chain related technical experts and marketing engineers during Research Team’s survey and interviews.

 Table of Contents
Chapter One Recombinant Human Insulin Industry Overview	1
1.1 Recombinant Human Insulin Definition	1
1.2 Recombinant Human Insulin Classification	2
1.3 Recombinant Human Insulin Industry Chain Structure	2
1.4 Recombinant Human Insulin Industry Overview	2
1.5 Recombinant Human Insulin Industry Policy Analysis	3
1.6 Recombinant Human Insulin Industry News Analysis	5

Chapter Two Recombinant Human Insulin International and China Market Analysis	7
2.1 Recombinant Human Insulin Industry International Market Analysis	7
2.1.1 Recombinant Human Insulin International Market Development History	7
2.1.2 Recombinant Human Insulin Product and Technology Developments	7
2.1.3 Recombinant Human Insulin International Competitive Landscape Analysis	9
2.1.4 Recombinant Human Insulin International Key Countries Development Status	10
2.1.5 Recombinant Human Insulin International Market Development Trend	11
2.2 Recombinant Human Insulin Industry China Market Analysis	11
2.2.1 Recombinant Human Insulin China Market Development History	11
2.2.2 Recombinant Human Insulin Product and Technology Developments	12
2.2.3 Recombinant Human Insulin China Competitive Landscape Analysis	13
2.2.4 Recombinant Human Insulin China Key Regions Development Status	14
2.2.5 Recombinant Human Insulin China Market Development Trend	15
2.3 Recombinant Human Insulin International and China Market Comparison Analysis	15

Chapter Three Recombinant Human Insulin Technical Data and Manufacturing Plants Analysis	16
3.1 2014 Global Key Insulin Manufacturing Plants Capacity and Commercial Production	16
3.2 2014 Global Key Manufacturers Recombinant Human Insulin Raw Materials Sources Analysis	16

Chapter Four Recombinant Human Insulin Major Countries Import Export Consumption	18
4.1 2009-2014 China Recombinant Human Insulin Supply Import Export Consumption	18
4.2 2009-2014 India Recombinant Human Insulin Supply Import Export Consumption	18
4.3 2009-2014 USA Recombinant Human Insulin Supply Import Export Consumption	19
4.4 2009-2014 France Recombinant Human Insulin Supply Import Export Consumption	19
4.5 2009-2014 Brazil Recombinant Human Insulin Supply Import Export Consumption	19
4.6 2009-2014 Russia Recombinant Human Insulin Supply Import Export Consumption	20

Chapter Five Recombinant Human Insulin Manufacturing Process and Cost Structure	21
5.1 Recombinant Human Insulin Product Specifications	21
5.1.1 Novo Nordisk Recombinant Human Insulin Product Specifications	21
5.1.2 Lilly Recombinant Human Insulin Product Specifications	22
5.2 Recombinant Human Insulin Manufacturing Process Analysis	22
5.3 Recombinant Human Insulin Cost Structure Analysis	23
5.4 Recombinant Human Insulin Cost Analysis	24

Chapter Six 2009-2014 Recombinant Human Insulin Productions Supply Sales Demand Market Status and Forecast	25
6.1 2009-2014 Recombinant Human Insulin Capacity Production (Million Pcs) Overview	25
6.2 2009-2014 Recombinant Human Insulin Production Market Share Analysis	32
6.3 2009-2014 Recombinant Human Insulin Demand Overview	43
6.4 2009-2014 Recombinant Human Insulin Supply Demand and Shortage	45
6.5 2009-2014 Recombinant Human Insulin Import Export Consumption	45
6.6 2009-2014 Recombinant Human Insulin Cost Price Production Value Gross Margin	46

Chapter Seven Recombinant Human Insulin Key Manufacturers Analysis	47
7.1 Novo Nordisk	47
7.1.1 Company Profile	47
7.1.2 Novo Nordisk Recombinant Human Insulin Product Picture and Specification	50
7.1.3 Novo Nordisk Recombinant Human Insulin Capacity Production Price Cost Production Value	50
7.1.4 Contact Information	51
7.2 Eli Lilly	52
7.2.1 Company Profile	52
7.2.2 Eli Lilly Recombinant Human Insulin Product Picture and Specification	55
7.2.3 Eli Lilly Recombinant Human Insulin Capacity Production Price Cost Production Value	56
7.2.4 Contact Information	57
7.3 Bioton	59
7.3.1 Company Profile	59
7.3.2 Bioton Recombinant Human Insulin Product Picture and Specification	59
7.3.3 Bioton Recombinant Human Insulin Capacity Production Price Cost Production Value	62
7.3.4 Contact Information	63
7.4 Dongbao	64
7.4.1 Company Profile	64
7.4.2 Dongbao Recombinant Human Insulin Product Picture and Specification	65
7.4.3 Dongbao Recombinant Human Insulin Capacity Production Price Cost Production Value	68
7.4.4 Contact Information	69
7.5 United Laboratories (TUL)	69
7.5.1 Company Profile	69
7.5.2 United Laboratories Recombinant Human Insulin Product Picture and Specification	73
7.5.3 United Laboratories Recombinant Human Insulin Capacity Production Price Cost Production Value	75
7.5.4 Contact Information	76

Chapter Eight Up and Down Stream Industry Analysis	78
8.1 Upstream Raw Materials Price Analysis	78
8.2 Upstream Equipment Market Analysis	78
8.3 Down Stream Demand Analysis	80
8.4 Industry Chain Analysis	81

Chapter Nine Recombinant Human Insulin Marketing Channels Analysis	82
9.1 Recombinant Human Insulin Marketing Channels Status	82
9.2 Recombinant Human Insulin Marketing Channels Characteristic	82
9.3 Recombinant Human Insulin Marketing Channels Development Trend	83

Chapter Ten Recombinant Human Insulin Industry Development Trend	88
10.1 2015-2020 Recombinant Human Insulin Capacity Production Overview	88
10.2 2015-2020 Recombinant Human Insulin Production Market Share Analysis	90
10.3 2015-2020 Recombinant Human Insulin Demand Overview	94
10.4 2015-2020 Recombinant Human Insulin Supply Demand and Shortage	95
10.5 2015-2020 Recombinant Human Insulin Import Export Consumption	95
10.6 2015-2020 Recombinant Human Insulin Cost Price Production Value Gross Margin	96

Chapter Eleven Recombinant Human Insulin Industry Development Proposals	97
11.1 Macroeconomic Development Countermeasures	97
11.1.1 Macroeconomic policy	98
11.1.2 Specific control measures	99
11.2 New Firms Enter Market Strategy	100
11.3 New Project Investment Proposals	102
11.4 Marketing Channel Strategy Proposals	103
11.5 Competitive Environment Strategy Proposals	104

Chapter Twelve Recombinant Human Insulin New Project Investment Feasibility Analysis	105
12.1 Recombinant Human Insulin Project SWOT Analysis	105
12.2 Recombinant Human Insulin New Project Investment Feasibility Analysis	105
12.2.1 Project Name	105
12.2.2 Investment Budget	105
12.2.3 Project Schedule	106
12.2.4 Benefit Analysis of Project	106

Chapter Thirteen Global and China Recombinant Human Insulin Industry Research Conclusions	108

Tables and Figures
Figure Recombinant Human Insulin product picture	1
Table Recombinant Human Insulin Classification	2
Figure Recombinant Human Insulin Industry Chain Structure	2
Figure 2013 International Recombinant Human Insulin Major Manufacturers Production Share	9
Figure 2013 Recombinant Human Insulin International Key Countries Production Share	10
Figure 2015-2020 Recombinant Human Insulin International Capacity Production and Growth Rate	11
Figure 2013 Recombinant Human Insulin China Key Regions Production Share	13
Figure 2013 Recombinant Human Insulin China Key Regions Production Share	14
Figure 2015-2020 Recombinant Human Insulin China Capacity Production and Growth Rate	15
Figure 2009-2014 International and China Capacity Production Comparison	15
Table 2014 Global Key Insulin Manufacturing Plants Capacity and Commercial Production (Million Pcs) Date	16
Table 2014 Global Key Manufacturers Recombinant Human Insulin Raw Materials Sources List	16
Table 2009-2014 China Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)	18
Table 2009-2014 India Supply Import Export Consumption (Million Pcs)	18
Table 2009-2014 USA Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)	19
Table 2009-2014 France Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)	19
Table 2009-2014 Brazil Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)	19
Table 2009-2014 Russia Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)	20
Figure Recombinant Human Insulin Manufacturing Process	23
Figure Recombinant Human Insulin Cost Structure Analysis	24
Figure Recombinant Human Insulin Cost Analysis	24
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Capacity and Total Capacity (Million Pcs) List	25
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Capacity Market Share List	25
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production and Total Production (Million Pcs) List	26
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Market Share List	26
Table 2009-2014 Global Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate	26
Table 2009-2014 Global Recombinant Human Insulin Capacity Utilization Rate List	26
Figure 2009-2014 Global Recombinant Human Insulin Capacity (Million Pcs) and Production Growth Rate	27
Figure 2009-2014 Global Recombinant Human Insulin Capacity Utilization Rate	27
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Capacity and Total Capacity (Million Pcs) List	27
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Capacity Market Share List	28
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production and Total Production (Million Pcs) List	28
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Market Share List	28
Table 2009-2014 China Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate	29
Table 2009-2014 China Recombinant Human Insulin Capacity Utilization Rate List	29
Figure 2009-2014 China Recombinant Human Insulin Capacity and Production Growth Rate	29
Figure 2009-2014 China Recombinant Human Insulin Capacity Utilization Rate	30
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Value (Million $) and Total Production Value List	30
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Value Market	30
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Value (Million $) and Total Production Value List	31
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Value Market Share List	31
Figure 2009 Global Major Manufacturers Recombinant Human Insulin Production Market Share	32
Figure 2009 China Major Manufacturers Recombinant Human Insulin Production Market Share	33
Figure 2010 Global Major Manufacturers Recombinant Human Insulin Production Market Share	34
Figure 2010 China Major Manufacturers Recombinant Human Insulin Production Market Share	35
Figure 2011 Global Major Manufacturers Recombinant Human Insulin Production Market Share	36
Figure 2011 China Major Manufacturers Recombinant Human Insulin Production Market Share	37
Figure 2012 Global Major Manufacturers Recombinant Human Insulin Production Market Share	38
Figure 2012 China Major Manufacturers Recombinant Human Insulin Production Market Share	39
Figure 2013 Global Major Manufacturers Recombinant Human Insulin Production Market Share	40
Figure 2013 China Major Manufacturers Recombinant Human Insulin Production Market Share	41
Figure 2014 Global Major Manufacturers Recombinant Human Insulin Production Market Share	42
Figure 2014 China Major Manufacturers Recombinant Human Insulin Production Market Share	43
Table 2009-2014 Global Recombinant Human Insulin Demand (Million Pcs) List	43
Figure 2009-2014 Global Recombinant Human Insulin Demand (Million Pcs) and Growth Rate	44
Table 2009-2014 China Recombinant Human Insulin Demand (Million Pcs) List	44
Figure 2009-2014 China Recombinant Human Insulin Demand (Million Pcs) and Growth Rate	44
Table 2009-2014 Global Recombinant Human Insulin Demand Supply Shortage (Million Pcs) List	45
Table 2009-2014 China Recombinant Human Insulin Demand Supply Shortage (Million Pcs) List	45
Table 2009-2014 China Recombinant Human Insulin Import Export Consumption (Million Pcs)	45
Table 2009-2014 Global Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List	46
Table 2009-2014 China Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List	46
Figure Novo Nordisk Network	48
Figure Novo Nordisk works with five strategic focus areas based on five core capabilities	48
Figure Global manufacturing setup	49
Figure Novo Nordisk’s position is protected by patents and value chain setup	49
Figure Novo Nordisk Recombinant Human Insulin Product Picture and Specification	50
Table 2009-2014 Novo Nordisk Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List	50
Figure 2009-2014 Novo Nordisk Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate	51
Figure 2009-2014 Novo Nordisk Recombinant Human Insulin Production Global Market Share	51
Figure Eli Lilly Recombinant Human Insulin Product Picture and Specification	56
Table 2009-2014 Eli Lilly Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List	56
Figure 2009-2014 Eli Lilly Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate	57
Figure 2009-2014 Eli Lilly Recombinant Human Insulin Production Global Market Share	57
Figure Bioton Million Pcs Gensulin M30 Recombinant Human Insulin Product Picture and Specification	61
Table 2009-2014 Bioton Million Pcs Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List	62
Figure 2009-2014 Bioton Million Pcs Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate	62
Figure 2009-2014 Bioton Recombinant Human Insulin Production Global Market Share	63
Figure Dongbao Gansulin R Recombinant Human Insulin Product Picture and Specification	65
Figure Dongbao Gansulin N Recombinant Human Insulin Product Picture and Specification	66
Figure Dongbao Gansulin 30R Recombinant Human Insulin Product Picture and Specification	67
Table 2009-2014 Dongbao Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List	68
Figure 2009-2014 Dongbao Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate	68
Figure 2009-2014 Dongbao Recombinant Human Insulin Production Global Market Share	69
Figure United Laboratories USLIN® N Recombinant Human Insulin Product Picture and Specification	73
Figure United Laboratories USLIN®50 Recombinant Human Insulin Product Picture and Specification	73
Figure United Laboratories USLIN®30 Recombinant Human Insulin Product Picture and Specification	74
Figure United Laboratories USLIN®R Recombinant Human Insulin Product Picture and Specification	74
Table 2009-2014 United Laboratories Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List	75
Figure 2009-2014 United Laboratories Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate	75
Figure 2009-2014 United Laboratories Recombinant Human Insulin Production Global Market Share	76
Figure Fermenter Picture	78
Figure Extraction system and Separation equipment	79
Figure Air purification systems	80
Figure Cold storage	80
Table 2009-2014 the Number of Diabetes (Million) and Diabetes Required Recombinant Human Insulin (Million) and Diabetes Growth Rate	81
Figure Recombinant Human Insulin Industry Chain	81
Figure Recombinant Human Insulin Marketing Channels Status	82
Table Recombinant Human Insulin Marketing Channels Characteristic Overview	82
Figure Marketing Channels Characteristic	83
Figure Flat Sales Channel Forms a Glance	84
Figure Partnership-type Relationship Sales Channels Form a Glance	86
Figure the export trend Overview	86
Figure 2015-2020 Global Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) and Growth Rate	88
Figure 2015-2020 China Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) and Growth Rate	89
Figure 2015 Global Recombinant Human Insulin Production Market Share	90
Figure 2020 Global Recombinant Human Insulin Production Market Share	91
Figure 2015 China Recombinant Human Insulin Production Market Share	92
Figure 2020 China Recombinant Human Insulin Production Market Share	93
Figure 2015-2020 Global Recombinant Human Insulin Demand (Million Pcs) and Growth Rate	94
Figure 2015-2020 China Recombinant Human Insulin Demand (Million Pcs) and Growth Rate	94
Table 2015-2020 Global Recombinant Human Insulin Demand (Million Pcs) Supply (Million Pcs) Shortage (Million Pcs) List	95
Table 2015-2020 China Recombinant Human Insulin Demand (Million Pcs) Supply (Million Pcs) Shortage (Million Pcs) List	95
Table 2015-2020 China Recombinant Human Insulin Import (Million Pcs) Export (Million Pcs) Consumption (Million Pcs)	95
Table 2015-2020 Global Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) Price ($/Pcs) Cost ($/Pcs) Gross ($/Pcs) Production Value (Million $) Gross Margin List	96
Table 2015-2020 China Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) Price ($/Pcs) Cost ($/Pcs) Gross ($/Pcs) Production Value (Million $) Gross Margin List	96
Table Macroeconomic Development Countermeasures Analysis	97
Table New Firms Enter Market Strategy	100
Table New Project Investment Proposals	102
Figure Recombinant Human Insulin Marketing strategy recommendations	103
Table Recombinant Human Insulin Marketing Channel Strategy Proposals	104
Table Competitive Environment Strategy Proposals	104
Table Recombinant Human Insulin Project SWOT Analysis	105
Table 100 Million Pcs Recombinant Human Insulin Project Appraisal and Financing	106
Table 100 Million Pcs Recombinant Human Insulin Project Construction Period	106
Table Annual Output of 100 Million Pcs Recombinant Human Insulin Project Return on Investment and Feasibility Analysis	106

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.